These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 33572388)
1. Prognostic Significance of Metabolic Parameters by Lee J; Cho YS; Kim J; Shim YM; Lee KH; Choi JY Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33572388 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic values of 2-[ Han S; Kim YI; Oh JS; Seo SY; Park MJ; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS Eur Radiol; 2022 Feb; 32(2):1173-1183. PubMed ID: 34448035 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas. Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902 [TBL] [Abstract][Full Text] [Related]
4. Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters. Park SY; Cho A; Bae MK; Lee CY; Kim DJ; Chung KY Clin Nucl Med; 2016 Jan; 41(1):15-20. PubMed ID: 26545017 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma. Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088 [TBL] [Abstract][Full Text] [Related]
6. Assessment of Mediastinal Tumors Using SUV Morita T; Tatsumi M; Ishibashi M; Isohashi K; Kato H; Honda O; Shimosegawa E; Tomiyama N; Hatazawa J Asia Ocean J Nucl Med Biol; 2017; 5(1):22-29. PubMed ID: 28840135 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma. Yoo J; Choi JY; Lee KT; Heo JS; Park SB; Moon SH; Choe YS; Lee KH; Kim BT Nucl Med Mol Imaging; 2012 Sep; 46(3):201-6. PubMed ID: 24900061 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer. Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative Hwang SH; Jung M; Jeong YH; Jo K; Kim S; Wang J; Cho A Cancer Metab; 2021 Jan; 9(1):8. PubMed ID: 33509304 [TBL] [Abstract][Full Text] [Related]
13. Intratumoral metabolic heterogeneity by Chao F; Wang R; Han X; Huang W; Wang R; Yu Y; Lin X; Yuan P; Yang M; Gao J Thorac Cancer; 2024 Jun; 15(18):1437-1445. PubMed ID: 38757212 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma. Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144 [TBL] [Abstract][Full Text] [Related]
15. The efficacy of Nakajo M; Takeda A; Katsuki A; Jinguji M; Ohmura K; Tani A; Sato M; Yoshiura T Br J Radiol; 2022 Jun; 95(1134):20211050. PubMed ID: 35312337 [TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma]. Wu LL; Liang JH; Wang L; Xu W; Ding CY Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850 [No Abstract] [Full Text] [Related]
17. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value. Satoh Y; Onishi H; Nambu A; Araki T Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640 [TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma]. Ding CY; Guo Z; Sun J; Yang WP; Li TR Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362 [No Abstract] [Full Text] [Related]
19. Prognostic usefulness of clinical features and pretreatment Chen D; Tang M; Lv S; Wang H; Du W; Zhao X; Lin L; Zhu Y; Wang G; Zhu H; Zhao K Quant Imaging Med Surg; 2022 May; 12(5):2792-2804. PubMed ID: 35502366 [TBL] [Abstract][Full Text] [Related]
20. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors. De Luca S; Fonti R; Palmieri G; Federico P; Del Prete G; Pacelli R; Pace L; De Placido S; Salvatore M; Del Vecchio S Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]